Archived Press Releases
The news releases presented here were believed to be accurate at the time they were issued and are provided for historical reference purposes only. They contain information that may no longer be accurate. Readers should not rely on the continued accuracy of any such material. All readers should carefully check the dates of issuance of the releases. NeurogesX assumes no obligation and does not intend to update, correct or otherwise modify any of these press releases regarding events that occur after their original release.
- December 1, 2005
NeurogesX Raises Million in Private Equity Financing - November 10, 2005
NeurogesX Adds Neil Kurtz, MD, To Board - June 15, 2005
NeurogesX Initiates Phase 3 Postherpetic Neuropathy Study with NGX-4010 - May 18, 2005
NeurogesX Announces Positive Phase 3 Result in Painful HIV-Associated Neuropathy Trial - February 2, 2005
NeurogesX Appoints Karen Harder as Senior Vice President, Regulatory and Technical Operations
